Irbesartan/Hydrochlorothiazide Eg

Irbesartan/Hydrochlorothiazide, the active ingredient in Irbesartan/Hydrochlorothiazide Eg, is an angiotensin II receptor blocker / thiazide diuretic presented as a strength/form not specified for oral use. It provides effective blood‑pressure control and is prescribed for adult patients with hypertension as part of a comprehensive cardiovascular risk management plan.

GNH USA supplies Irbesartan/Hydrochlorothiazide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union regulatory standards.

Irbesartan/Hydrochlorothiazide Eg is indicated for hypertension, a condition characterized by chronically elevated arterial pressure.

Hypertension: lowers systolic and diastolic blood pressure, helping to reduce the risk of cardiovascular events.

Adverse reactions to Irbesartan/Hydrochlorothiazide Eg may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte disturbances such as low potassium - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe dehydration or electrolyte imbalance - Acute kidney injury or sudden rise in serum creatinine - Severe allergic reactions (rash, hives, anaphylaxis) - Hyperuricemia leading to gout attacks

When prescribing Irbesartan/Hydrochlorothiazide Eg, clinicians should consider several safety measures. - Blood pressure monitoring: check regularly to ensure therapeutic response. - Electrolyte assessment: monitor serum potassium and sodium levels, especially in patients on other diuretics. - Renal function: evaluate creatinine and eGFR before initiation and during therapy. - Diabetes mellitus: use caution as thiazide component may affect glucose control. - Pregnancy: avoid unless clearly indicated, as safety data are limited. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Irbesartan/Hydrochlorothiazide Eg can interact with several medicines; awareness of the interaction potential helps maintain safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors or ARBs combined with aliskiren in diabetic patients: increased adverse events. - Lithium: thiazide component may raise lithium levels, risking toxicity. - NSAIDs: may blunt antihypertensive effect and affect renal function. - Cyclosporine: combined use may increase nephrotoxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure lowering may cause excessive hypotension. - Corticosteroids: may enhance potassium loss. - Antidiabetic agents: thiazide may elevate blood glucose, requiring dose adjustment.